The extracellular concentration of glutamate ([Glu] o ) is limited by the function of glutamate transporters located in both neuronal and glial membranes in the central nervous system.
The activity of glutamate transporters has been studied by measuring the uptake or release of radiolabelled glutamate in COS cells or Xenopus oocytes expressing glutamate transporters. 4, 14) These heterologous expression systems are not suitable for studying reversed transport because these cell systems do not necessarily mimic conditions in the brain, such as the intracellular glutamate concentration, which affect the reversed transport. Furthermore, pre-existing glutamate often interferes with the transport of radiolabelled glutamate. In the present study, in order to evaluate the effects of drugs on both the forward and reversed transport of glutamate, we examined the effects of Na ϩ -concentration and pharmacological agents on external glutamate concentration in a rat cortical synaptosome preparation.
MATERIALS AND METHODS

Animals
All experiments were performed under regulation of the Animal Ethics Committee of Tanabe Seiyaku Co., Ltd. Male Wistar strain rats weighing 200-400 g were used for the preparation of crude synaptosomal fractions.
Preparation of Crude Synaptosomal Fractions Crude synaptosomal fractions were prepared following the standard procedures. 15) Rats were anesthetized with ether, and whole brains were removed after decapitation. The cerebral cortex, isolated under an ice-cold condition, was homogenized in a 5-fold volume of 0.32 M sucrose. The homogenate was centrifuged at 1500ϫg for 10 min, and the supernatant was centrifuged at 9000ϫg for 20 min. The pellet (P2 fraction) was suspended in 0.32 M sucrose solution again and centrifuged at 9000ϫg for 20 min. The above procedures were carried out at 4°C. The pellet was resuspended in 0.32 M sucrose, then used as a crude synaptosome preparation in the following experiments. The protein content of the crude synaptosome preparation was 6.78Ϯ0.11 mg/ml (meanϮS.E., nϭ37). The glutamate content in the synaptosomal preparation is of intrinsic origin.
Determination of Extracellular Glutamate in Synaptosomal Preparation Fifty microliters of the crude synaptosome preparation was added to 1 ml of standard HEPES buffered saline (HBS) medium containing 140 mM NaCl, 5 mM KCl, 5 mM NaHCO 3 , 1 mM MgCl 2 , 0.12 mM Na 2 SO 4 , 10 mM glucose, and 20 mM HEPES (pH 7.4) on ice with or without drug. In order to evoke the glutamaterelease by depolarization, we prepared a high-K solution by adding 20 ml of 4 M KCl and 1 ml of 2 M CaCl 2 into HBS medium. The reaction was started by transferring the incubation tube into a 37°C water bath. The ice-cold medium reached 37°C in 60 to 70 s. After incubation at 37°C for up to 6 min, except for the experiments in Fig. 1 , the reaction was stopped by immediately transferring the incubation tube into an ice-cold water bath. It took 70 to 80 s to reach 10°C or less from 37°C. Then, the synaptosomes were centrifuged at 9000ϫg for 20 min at 4°C, and the supernatants were stocked at Ϫ80°C until the measurement of glutamate. The concentration of glutamate in the supernatants was determined using the glutamate dehydrogenase-NADP ϩ method. 16) The difference in glutamate concentration in each media before and after incubation was expressed as
o represent an increase in glutamate outside synaptosomes, whereas "negative" values represent a decrease in glutamate outside synaptosomes.
Chemicals The following materials were of reagent grade and obtained from commercial sources: sucrose, choline chloride, HEPES (Nacalai Tesque Co. Ltd, Tokyo); (Fig. 4) 
DISCUSSION
Glutamate is co-transported with Na ϩ and H ϩ and countertransported with K ϩ via glutamate transporters. 6, 9, 18) Because forward and reversed transport of glutamate is affected by the concentration gradients of these ions across plasma membrane as well as the membrane potential, we examined the effect of external Na ϩ concentration on glutamate transport in the synaptosome preparation. Synaptosomes were prepared from a homogenate of rat cerebral cortex. Due to leaking of glutamate from cells by this operation, the glutamate concentration outside of synaptosomes in this study was higher than that under physiological condition. The higher the glutamate concentration, the more pronounced the driving force of uptake. Thus, the influence of various treatments on the uptake system using synaptosomes can be easily detected.
In the present study, we showed that [Glu] o in the synaptosome preparations was changed depending on temperature and Na ϩ concentration of the incubation medium. Glutamate was taken up by synaptosomes at a physiological concentration of extracellular Na DHK, a non-transportable inhibitor selective for GLT-1, 21, 22) upwardly shifted the [Na (Fig. 5 ). The area surrounded by two curves in the presence and absence of DHK is supposed to represent the uptake of glutamate into the glial component by DHK-sensitive GLT-1. The area under the curve for DHK and over the x axis may represent the reversed transport via DHK-insensitive glutamate transporters, such as EAAC1. The synaptosome fraction consists of both glial and neuronal components.
23) The intracellular glutamate concentrations are 50 mM and 1 mM for glia and neurons, respectively. 24) Because of the high concentration of glutamate in neurons, the conversion of uptake/reversed uptake in neurons takes place at a higher extracellular Na ϩ concentration than in the glia. While the neuronal glutamate transporters are functionally converted from an uptakepredominant to a release-predominant state by a reduction in Na ϩ from 145.2 mM to about 60 mM, the uptake of glutamate by glial GLT-1 is maintained. GLT-1 may contribute to the uptake rather than the reversed transport in this assay system. In the low Na ϩ condition, DHK slightly increased but did not decrease [Glu] o , and thus, it is presumed to be a typical uptake inhibitor without any effect on the reversed transport.
Glutamate transporters mediate not only substrate uptake and reversed transport but also the heteroexchange of substrates in a Na ϩ dependent manner. 20 25) we analyzed the effect of some glutamate-related compounds on [Glu] o in this assay system. Among the glutamate analogs tested, (Ϯ)-b-phenyl- glutamic acid significantly suppressed both the elevation of [Glu] o in low Na ϩ medium and the reduction of [Glu] o in standard HBS medium. This compound is, thus, proposed to inhibit both uptake by glial transporters and reversed transport by neural transporters. This beneficial action of (Ϯ)-bphenylglutamic acid, to our knowledge, has not been reported. The potential of this compound to suppress ischemiainduced brain damage is to be examined.
Previously, the transport of glutamate has been characterized using radiolabelled glutamate in COS cells or in Xenopus oocytes expressing glutamate transporters. 4, 14) There was, however, a limitation of these heterologous expression systems to analyze the glutamate release because these cell systems do not necessarily mimic conditions in brain, such as intracellular glutamate concentration, which affects the reversed transport. Furthermore, possible interference of the transport of labeled glutamate by pre-existing glutamate cannot be excluded. The measurement of [Glu] o has several advantages over the previous methods, as follows: (1) extracellular glutamate is determined without using radiolabelled compounds, (2) the synaptosome preparations (P2 fraction) contain both neuronal and glial components, including intrinsic glutamate, and (3) transportable and non-transportable inhibitors can be distinguished.
In conclusion, we developed an in vitro assay system to evaluate the effect of drugs on the uptake and reversed transport of glutamate in synaptosomes. Because extracellularly released glutamate plays a crucial role in ischemic brain damage, this assay system would be useful for the evaluation of neuroprotective agents that affect glutamate transporters.
